|
Roche Holding AG Basel American Depositary Shares (OP:RHHBY)
Delayed: 65.65
--0 (-0%)
|
Trade Now! |
|
| Previous Close |
$65.65 |
|
52 Week High |
$66.52 |
|
| Open |
$65.90 |
|
52 Week Low |
$38.63 |
| Day High |
$66.52 |
|
P/E |
N/A |
| Day Low |
$65.50 |
|
EPS |
$0.00 |
| Volume |
453,688 |
|
|
|
-
May 15, 2013 06:00 PM
Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer
-
May 15, 2013 01:00 AM
Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO
-
May 14, 2013 07:14 PM
FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer
-
May 10, 2013 03:58 PM
Roche (RHHBY) Spokesperson: Illumina (ILMN) Still 'Off the Table'
-
Apr 30, 2013 11:31 AM
Roche's (RHHBY) Genentech Receives FDA Approval for ACTEMRA as PJIA Treatment
-
Apr 30, 2013 11:30 AM
FDA Approves ACTEMRA® for Children Living with a Rare Form of Arthritis
-
Apr 22, 2013 01:46 AM
Evotec Extends Drug Discovery Alliance With Genentech
-
Apr 16, 2013 11:42 AM
UPDATE: Glaxo (GSK) wins appeals court ruling over Biogen Idec (BIIB) cancer patent
-
Apr 11, 2013 08:15 AM
Roche Holding (RHHBY) Reports 5.1% Growth in Q1 Sales
-
Apr 8, 2013 09:02 AM
Roche (RHHBY), Isis Pharma (ISIS) Enter Huntington's Disease Agreement; Value to Isis at $362M
View All Articles
-
May 10, 2013 03:58 PM
Roche (RHHBY) Spokesperson: Illumina (ILMN) Still 'Off the Table'
-
Apr 30, 2013 11:31 AM
Roche's (RHHBY) Genentech Receives FDA Approval for ACTEMRA as PJIA Treatment
-
Apr 16, 2013 11:42 AM
UPDATE: Glaxo (GSK) wins appeals court ruling over Biogen Idec (BIIB) cancer patent
-
Apr 11, 2013 08:15 AM
Roche Holding (RHHBY) Reports 5.1% Growth in Q1 Sales
-
Apr 8, 2013 09:02 AM
Roche (RHHBY), Isis Pharma (ISIS) Enter Huntington's Disease Agreement; Value to Isis at $362M
-
Mar 19, 2013 01:09 PM
UPDATE: Shares of Life Technologies (LIFE) Spike, Potential Roche Bid
-
Feb 22, 2013 09:26 AM
Roche's (RRHBY) Genentech Receives FDA Approval for Kadcyla (IMGN)
-
Feb 1, 2013 01:40 PM
Alimera (ALIM), pSivida (PSDV) Move Higher as Journal Questions Lucentis Effectiveness
-
Feb 1, 2013 01:25 PM
Unusual 11 Mid-Day Movers 02/01: (OTT) (BBW) (ALIM) Higher; (ECTE) (BCOV) (LTM) Lower
-
Jan 29, 2013 12:10 PM
Streetinsider.com's Hot Lunchtime Reads 01/29: (AMGN) (TRV) (STX) (ECA)
View All Reports